Pulmonary Function Testing & Preparation | NYU Langone Health
Breathing tests are performed at the Pediatric Pulmonary Function Laboratory, part of Hassenfeld Children’s Hospital at NYU Langone.
Pulmonary Intervention for Airway Conditions | NYU Langone Health
Interventional pulmonologists at NYU Langone’s Tracheal and Bronchial Disorders Treatment Program diagnose and manage conditions of the trachea and bronchi.
Pulmonary Rehabilitation | NYU Langone Health
The Pulmonary Rehabilitation Program at NYU Langone’s Rusk Rehabilitation helps people overcome lung and breathing-related conditions.
Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis | NYU Langone Health
NYU Langone rehabilitation specialists are experts in pulmonary rehabilitation for idiopathic pulmonary fibrosis.
Pulmonary Rehabilitation Program at NYU Langone Hospital—Suffolk | NYU Langone Health
The Pulmonary Rehabilitation Program at NYU Langone Hospital—Suffolk helps people manage pulmonary disease.
Pulse lntravascular Lithotripsy (Pulse IVL ) to Open Vessels with Calcific Walls and Enhance Vascular Compliance and Remodeling for Peripheral Artery Disease
This study aims to demonstrate the safety and effectiveness of the Amplitude Vascular System (AVS) Pulse Intravascular Lithotripsy™ (Pulse IVL™) System for treatment of certain arteries (calcified (moderate to severe), stenotic, superficial femoral and popliteal arteries) in patients with peripheral arterial disease (buildup on the walls of the blood vessels in a patient’s legs).
Quantitative Brain MRI in Multiple Sclerosis and Healthy Controls
The purpose of this study is to evaluate a novel quantitative MRI approach for the detection of subtle abnormalities in normal-appearing brain tissue in multiple sclerosis (MS). The study is enrolling participants with a confirmed diagnosis of MS, as well as healthy volunteers. The study aims to investigate whether the novel MRI approach can help in predicting clinical progression for MS patients.
Queens Locations | NYU Langone Health
See all NYU Langone locations in Queens and find locations in your neighborhood.
Race-spEcific regional Tau deposition and role of Obstructive Sleep Apnea (RETOSA)
This proposal will generate pilot data for an R01 application that aims to determine whether Blacks/African Americans (‘blacks’) generally exhibit lower tau-PET signal compared to non-Hispanic whites (‘whites’) for a given level of global Aß burden, and further determine the effect of obstructive sleep apnea (OSA) as a possible race-related biologic mechanism on this signal. To do this, we will leverage data and resources from NYU Alzheimer’s Disease Research Center (ADRC NYULH STUDY ID#: s20-00427) and two affiliated ongoing NIH supported R01 studies (2R01AG056031 NYULH STUDY ID#: s17-01005 and 1R01AG056531 NYULH STUDY ID#: s18-01302). All studies have neuroimaging measures of vascular burden, and amyloid. NYULH STUDY ID#: s17-01005 and NYULH STUDY ID#: s20-00427 have tau-PET neuroimaging using 18F-PI2620 or 18F-MK6240 MR scans. NYULH STUDY ID#: s17-01005 and NYULH STUDY ID#: s18-01302 have nocturnal polysomnography (NPSG) recordings. This study adds tau-PET neuroimaging using 18F-PI2620 or 18F-MK6240 MR scan to 24 black subjects in 1R01AG056531 NYULH STUDY ID#: s18-01302. Altogether, subjects will include 120 cognitively normal (60 controls [30 blacks & 30 whites recruited from both NYULH STUDY ID#: s18-01302 & NYULH STUDY ID#: s20-00427) and 60 newly diagnosed OSA subjects with complaints of EDS [30 blacks & 30 whites]), ages 60-75 (recruited from NYULH STUDY ID#: s17-01005) relatively matched on or similar in age (60-75 range), sex, BMI, education and income.
Racial diffErences in the aSsociation Of sLow waVe slEep aNd Tau (RESOLVENT II)
This pilot proposal will examine whether racial differences exist in the association between SWS/SWA and in-vivo regional tau-PET signal for a given level of global Aß burden. To generate preliminary data for a larger R01 application, we will leverage data and resources from NYU Alzheimer’s Disease Research Center (ADRC NYULH STUDY ID#: s20-00427) and two affiliated ongoing NIH supported R01 studies (2R01AG056031 NYULH STUDY ID#: s17-01005 and 1R01AG056531 NYULH STUDY ID#: s18-01302). Altogether, subjects will include 100 cognitively normal (50 blacks from NYULH STUDY ID#: s18-01302 & 50 whites {35 from NYULH STUDY ID#: s17-01005 & 15 from NYULH STUDY ID#: s20-00427 ) without OSA (thereby eliminating a possible confounder of reduced SWS), ages 60-75, matched on age, sex, BMI, education and income.